Studies conducted by Li et al. revealed that the silencing of STAT3 in the hepatocellular carcinoma model reduced glycolysis-related gene—Hexokinase 2 (HK2)—expression observed at the mRNA and protein levels. This evidence concerns the gene HK2 and hepatocellular carcinoma.